Welcome to our dedicated page for 3-D Sys Del news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3-D Sys Del stock.
3D Systems Corporation (NYSE: DDD), a pioneer in additive manufacturing and digital dentistry solutions, provides investors and industry professionals with critical updates through this centralized news hub. Track official press releases, financial disclosures, and strategic developments from the company redefining 3D printing applications across healthcare, aerospace, and industrial manufacturing.
This resource offers timely access to earnings announcements, regulatory filings, and innovation milestones. Users will find updates on advanced manufacturing technologies like the Oqton Manufacturing OS, healthcare breakthroughs in patient-specific medical devices, and industrial applications of QuickCast Air investment casting solutions.
Key content categories include quarterly financial results, product launches, strategic partnerships, and regulatory compliance achievements. The curated collection serves as a reliable reference for assessing 3D Systems' market position and technological leadership in high-precision manufacturing.
Bookmark this page to stay informed about DDD's progress in materials science advancements, software platform enhancements, and global manufacturing initiatives. Check regularly for verified updates directly impacting investment decisions and industry analysis.
3D Systems (NYSE: DDD) has achieved a significant milestone in medical technology by enabling the world's first Medical Device Regulation (MDR)-compliant 3D-printed PEEK facial implant at the point-of-care. The breakthrough was accomplished in collaboration with the University Hospital Basel, Switzerland, where surgeons successfully implanted the device on March 18, 2025.
The implant was produced using VESTAKEEP® i4 3DF PEEK on 3D Systems' EXT 220 MED printer, which features cleanroom-based architecture and simplified post-processing workflows. Since its launch in August 2023, the EXT 220 MED has been used in over 80 successful cranial implant surgeries at partner hospitals.
The 3D-printed maxillofacial implant market is projected to grow from over $2 billion in 2024 to more than $4 billion by 2034. 3D Systems has already worked with surgeons to plan more than 150,000 patient-specific cases and manufacture over two million implants and instruments for 100+ CE-marked and FDA-cleared devices.
3D Systems (NYSE: DDD) unveils groundbreaking manufacturing solutions at RAPID+TCT 2025, introducing three key innovations:
- The Figure 4 135 3D printer with Figure 4 Tough 75C FR Black material, designed for high-mix, low-volume manufacturing, reducing costs significantly for precision applications
- A new module for EXT Titan Pellet printers that improves process efficiency up to 60% through enhanced part solidity optimization and print bed mapping
- The QuickCast Diamond build style for PSLA 270 technology, advancing investment casting pattern production
The Figure 4 135 solution targets industries requiring high precision with a process capability index of 1.33 or above. The new EXT Titan Pellet module, available in Q3 2025, reduces post-processing time by up to 50%. These innovations reflect 3D Systems' continued R&D investment and commitment to application-specific manufacturing solutions.
3D Systems (NYSE:DDD) has completed the sale of its Geomagic® software portfolio to Hexagon's Manufacturing Intelligence Division for $123 million, expecting net proceeds of approximately $100 million. The transaction strengthens the company's balance sheet and allows focus on core additive manufacturing software platforms.
The company will concentrate on advancing its key software solutions: 3D Sprint®, 3DXpert®, and Oqton Industrial Manufacturing OS. 3D Systems plans to enhance these platforms by leveraging artificial intelligence and automation to accelerate 3D printing adoption in high-volume production environments.
3D Systems (NYSE:DDD) reported full-year 2024 revenue of $440 million, meeting the lower end of guidance despite a $9 million Q4 revenue reduction due to accounting changes in their Regenerative Medicine program. Q4 revenue decreased 3% to $111 million year-over-year.
The company announced a new cost reduction initiative targeting over $50 million in incremental annualized savings through 2025 and first-half 2026. The upcoming sale of their Geomagic software platform for $123 million is expected to close in early April, strengthening their balance sheet which showed $171 million in cash as of December 31, 2024.
For 2025, 3D Systems forecasts revenue between $420-435 million, representing flat to modest organic growth excluding Geomagic. They aim to achieve break-even or positive adjusted-EBITDA by Q4 2025. The company saw improved Q4 industrial printer systems sales and healthy consumable sales, though 2024 was challenging due to weak customer capital spending.
3D Systems (NYSE:DDD) has scheduled the release of its fourth quarter and full year 2024 financial results after market close on Wednesday, March 26, 2025. The company will also provide guidance for 2025 during this announcement.
A conference call and simultaneous webcast to discuss these results will be held on Thursday, March 27, 2025, at 8:30 a.m. Eastern Time. Investors can participate via webcast at www.3dsystems.com/investor or by telephone at 201-689-8345. A replay of the webcast will be available approximately two hours after the conference call concludes.
3D Systems (NYSE:DDD) has announced its participation in the upcoming Cantor Global Technology Conference scheduled for March 11, 2025. The company's President and CEO, Dr. Jeffrey Graves, will engage in a fireside chat at 2:20 p.m. Eastern Standard Time and conduct individual meetings with the company's leadership team throughout the day.
A live webcast of the conference presentation will be accessible through 3D Systems' Investor Relations page. The webcast link will become active shortly before the event begins and will be available for on-demand viewing approximately 24 hours after the event concludes, with -time access following the conference.
3D Systems (NYSE: DDD) has unveiled new dental innovations at LMT Lab Day 2025, including the NextDent® Jetted Denture Solution and the NextDent® 300 MultiJet 3D printer for multi-material monolithic dentures. The printer can produce 15 arches in nine hours, with general availability expected in Q3 2025.
The company plans to expand into night guards (late 2025) and direct-printed aligners (2026). Currently, their technology enables the production of approximately one million patient-specific clear aligners daily. The company's portfolio includes materials for over 30 dental applications, serving more than one million patients daily.
The global dental 3D printing market is projected to reach $14.6 billion by 2032. The NextDent® 300 utilizes specialized materials - NextDent® Jet Teeth and NextDent® Jet Base - as part of an FDA-cleared workflow solution for high-volume dental laboratories.
3D Systems (NYSE: DDD) announced that Charles (Chuck) Hull, co-founder and chief technology officer for regenerative medicine, has been elected to the National Academy of Engineering (NAE). Hull, who invented 3D printing and pioneered Stereolithography (SLA), created the first 3D-printed part in 1983 and co-founded 3D Systems in 1986.
Hull's achievements include receiving the National Medal of Technology and Innovation from President Biden in 2023, induction into the National Inventors Hall of Fame (2014), and the European Inventor Award (2014). He holds 85 US patents and numerous international patents in ion optics and 3D printing. His invention of SLA launched the commercial 3D printing industry with the first printer, the SLA-1.
Hull will be formally inducted during the NAE's Annual Meeting on October 5, 2025, along with 128 new members and 22 international members in the Class of 2025.
Systemic Bio, a 3D Systems (NYSE: DDD) company, has won the prestigious SLAS 2025 Innovation Award for its groundbreaking technological advancements in laboratory science. The award recognizes the company's proprietary h-VIOS™ platform, which accelerates drug discovery using bioprinted human tissues.
The company's winning presentation demonstrated the platform's ability to evaluate antibody-drug conjugates (ADCs) safety, identifying risks typically only discovered during clinical trials. Operating from Houston, Texas, Systemic Bio maintains an ISO 7 clean room and Quality Management System, enabling the production of thousands of tissue models.
CEO Taci Pereira emphasized the award's significance as validation of their platform's scientific value. The company continues collaborating with leading pharmaceutical companies to enhance preclinical drug testing and reduce late-stage failures through their innovative technology.
3D Systems (NYSE: DDD) and Daimler Truck | Daimler Buses have announced a groundbreaking solution for remote spare part printing. The collaboration, which includes Oqton and Wibu-Systems, enables Daimler Buses' certified partners to produce spare parts locally while protecting intellectual property through digital rights management.
The solution allows for on-demand manufacturing of various underhood and cabin interior parts, reducing delivery time by up to 75%. Service providers can join Daimler's network by purchasing a 3DXpert license through their Omniplus 3D-Printing License eShop. The system currently works with 3D Systems' SLS 380 printer, with plans to expand to other polymer and metal printers.
This initiative aims to overcome supply chain bottlenecks and minimize vehicle downtime due to maintenance. The automotive additive manufacturing market is projected to grow from $2.9 billion in 2022 to $7.9 billion by 2027.
